Taj, M. B. Et Al. 2023. Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations. PLoS ONE , vol.18, no.2 February .

Taj, M. B., Raheel, A., Ayub, R., Alnajeebi, A. M., Abualnaja, M., Habib, A. H., ... Alelwani, W.(2023). Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations. PLoS ONE , vol.18, no.2 February.

Taj, Muhammad Et Al. "Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations," PLoS ONE , vol.18, no.2 February, 2023

Taj, Muhammad B. Et Al. "Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations." PLoS ONE , vol.18, no.2 February, 2023

Taj, M. B. Et Al. (2023) . "Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations." PLoS ONE , vol.18, no.2 February.

@article{article, author={Muhammad Babar Taj Et Al. }, title={Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations}, journal={PLoS ONE}, year=2023}